You wrote a check into an early-stage company on a SAFE. Part of what you are underwriting — maybe a large part — is the hope that when this thing works, your gain comes out tax-free under Section 1202. So here is an uncomfortable question: if that exit arrives in seven years and the IRS asks you to prove the company was a qualified small business the whole way through, what exactly are you holding?
For most angels investing on a SAFE, the answer is: a SAFE. That's it. No information rights. No covenant about QSBS. No protective provisions on redemptions. Nothing that obligates the company to tell you, ever, whether the facts underlying your exclusion are still true. A priced-round investor at least gets the (admittedly weak) QSBS covenant buried in the NVCA Investors' Rights Agreement. The SAFE angel gets nothing at all. You are the most exposed investor on the cap table, and you are the one counting on the biggest tax break.
The SAFE has two QSBS problems, not one
The first problem is whether your SAFE is even stock. Section 1202 excludes gain from the sale of qualified small business stock, and only the issuance of stock starts the multi-year holding-period clock. A SAFE is a hybrid — not debt, not quite equity, a contractual right to future shares. The IRS has never said whether a SAFE counts as stock for Section 1202, and there is no sign it intends to. There is a reasonable basis to treat a SAFE as equity, since it lacks the defining features of debt — no maturity date, no fixed sum owed, no interest. Y Combinator's own SAFE even recites that the parties intend it to be treated as stock for these purposes. But that recital does not bind the IRS, and the question remains genuinely unsettled.
Why does that matter so much to you specifically? Because of timing. If your SAFE is stock, your holding-period clock starts when you fund it, and the conversion into preferred stock later simply continues the run. If your SAFE is not stock, the clock does not start until the SAFE actually converts into equity — which, on a hot company, might be years down the road. With the post-OBBBA tiers now running 50% at three years, 75% at four, and 100% at five, where the clock starts can be the difference between a full exclusion and a partial one, or none at all. And it gets sharper if you are rolling QSBS proceeds into a SAFE under Section 1045: there, the replacement interest has to be QSBS on the date it is issued, and if the SAFE is not stock, the rollover can fail outright. That is a bet-the-farm version of the same uncertainty.
The second problem is the one I wrote about for founders last week, and it applies to you with equal force: even once you clearly hold stock, the company has to keep qualifying. The active-business requirement must be satisfied during substantially all of your holding period. The company can drift over the gross-asset ceiling, pivot into a line of business that isn't qualified, load up on real estate or a securities portfolio beyond the 10% limits, or do a redemption that taints the stock — and you, sitting on a bare SAFE, would have no contractual right to know any of it until you are trying to reconstruct the facts after the sale.
The fix is a one-page side letter
Here is the good news for the angel: you do not have to wait for the NVCA to fix its forms, and you do not need a priced round to get protected. You can solve this on your own deal, today, with a short side letter delivered alongside your SAFE. Founders raising on SAFEs are generally raising fast and rarely fight a brief, investor-protective side letter — and this one asks for almost nothing operationally burdensome.
What the side letter should secure, at a minimum: a commitment that the company will use commercially reasonable efforts to qualify and preserve the stock as QSBS; advance notice before the company takes any action that would reasonably be expected to disqualify it (a redemption, a disqualifying acquisition, blowing past the gross-asset cap); the factual information you would need to make your own QSBS determination; and — the piece nobody includes and everybody should — an annual certification, signed by the company's principal financial officer, of the facts that underlie the Section 1202 qualification, for as long as you hold the SAFE or the stock it becomes.
That last item is the whole game. It converts your QSBS position from "we'll reconstruct it someday" into a contemporaneous, signed, year-by-year record built while the people who know the facts are still in the building. For the company's CFO, it is perhaps an hour of work a year. For you, it is the difference between walking into an audit with a clean file and walking in with a shrug.
Why this is a rational ask, not a nuisance
Think about the asymmetry. You are potentially sheltering the greater of $15 million or ten times your basis, per company, from federal tax. The cost of protecting that is a one-page document at signing and an hour of CFO time each year. No serious investor would skip insurance that cheap on an asset that valuable — yet on SAFEs, almost everyone does, because the standard paper simply doesn't include it and nobody thinks to ask.
So ask. If you are writing SAFE checks and you care about your Section 1202 outcome — and if you didn't, you wouldn't be reading this — make the annual QSBS certification a standard term of your own investing. Put it in your side letter the way you put a pro rata right or an information right in your side letter. The company that won't give you a factual certification about its own qualification is telling you something, and the company that will has just handed you the best audit defense money can buy, for almost no money at all.
This is commentary on investment documentation and Section 1202, not legal or tax advice, and whether any particular SAFE is "stock" for Section 1202 turns on specific facts that deserve a real analysis. If you want help building a QSBS side letter into your angel investing process — or an annual certification process on the company side — that is something we do.
